NO20045132L - Benzo(c)kinolizinderivater, deres fremstilling og anvendelse som 5alfa- reduktaseinhibitorer - Google Patents

Benzo(c)kinolizinderivater, deres fremstilling og anvendelse som 5alfa- reduktaseinhibitorer

Info

Publication number
NO20045132L
NO20045132L NO20045132A NO20045132A NO20045132L NO 20045132 L NO20045132 L NO 20045132L NO 20045132 A NO20045132 A NO 20045132A NO 20045132 A NO20045132 A NO 20045132A NO 20045132 L NO20045132 L NO 20045132L
Authority
NO
Norway
Prior art keywords
benzo
preparation
5alpha
reductase inhibitors
quinolizine derivatives
Prior art date
Application number
NO20045132A
Other languages
English (en)
Inventor
Antonio Guarna
Mario Serio
Original Assignee
Applied Research Systems
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Publication of NO20045132L publication Critical patent/NO20045132L/no
Application filed by Applied Research Systems filed Critical Applied Research Systems

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D455/00—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
    • C07D455/03—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing quinolizine ring systems directly condensed with at least one six-membered carbocyclic ring, e.g. protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
    • C07D455/04—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing quinolizine ring systems directly condensed with at least one six-membered carbocyclic ring, e.g. protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing a quinolizine ring system condensed with only one six-membered carbocyclic ring, e.g. julolidine
    • C07D455/06—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing quinolizine ring systems directly condensed with at least one six-membered carbocyclic ring, e.g. protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing a quinolizine ring system condensed with only one six-membered carbocyclic ring, e.g. julolidine containing benzo [a] quinolizine ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/28—Antiandrogens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D455/00—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Abstract

Foreliggende oppfinnelse angår benzo[c]kinolizinderivater med generell formel (I), deres farmasøytiske akseptable salter eller estere, fremgangsmåte til deres fremstilling og farmasøytiske sammensetninger om inneholder forbindelsene.
NO20045132A 1996-02-09 2004-11-24 Benzo(c)kinolizinderivater, deres fremstilling og anvendelse som 5alfa- reduktaseinhibitorer NO20045132L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT96FI000019A IT1286545B1 (it) 1996-02-09 1996-02-09 Derivati benzo(c) chinolizinici,loro preparazione ed uso come inibitori delle 5-alfa-riduttasi
PCT/EP1997/000552 WO1997029107A1 (en) 1996-02-09 1997-02-07 BENZO[C]QUINOLIZINE DERIVATIVES, THEIR PREPARATION AND USE AS 5α-REDUCTASES INHIBITORS

Publications (1)

Publication Number Publication Date
NO20045132L true NO20045132L (no) 1998-07-24

Family

ID=11351478

Family Applications (2)

Application Number Title Priority Date Filing Date
NO19983444A NO320155B1 (no) 1996-02-09 1998-07-24 Benzo(c)kinolizinderivater, deres fremstilling, farmasoytisk sammensetning som inneholder derivatene, og anvendelse av derivatene til a fremstille et legemiddel
NO20045132A NO20045132L (no) 1996-02-09 2004-11-24 Benzo(c)kinolizinderivater, deres fremstilling og anvendelse som 5alfa- reduktaseinhibitorer

Family Applications Before (1)

Application Number Title Priority Date Filing Date
NO19983444A NO320155B1 (no) 1996-02-09 1998-07-24 Benzo(c)kinolizinderivater, deres fremstilling, farmasoytisk sammensetning som inneholder derivatene, og anvendelse av derivatene til a fremstille et legemiddel

Country Status (26)

Country Link
US (3) US6303622B1 (no)
EP (1) EP0880520B1 (no)
JP (1) JP2000504680A (no)
KR (1) KR100480448B1 (no)
CN (1) CN1116296C (no)
AT (1) ATE237614T1 (no)
AU (1) AU711886C (no)
BG (1) BG64596B1 (no)
CZ (1) CZ298061B6 (no)
DE (1) DE69720966T2 (no)
DK (1) DK0880520T3 (no)
EA (1) EA000975B1 (no)
EE (1) EE04058B1 (no)
ES (1) ES2192263T3 (no)
HK (1) HK1018783A1 (no)
HU (1) HUP9900509A3 (no)
IL (2) IL125628A0 (no)
IT (1) IT1286545B1 (no)
MX (1) MX9806229A (no)
NO (2) NO320155B1 (no)
NZ (1) NZ331256A (no)
PL (1) PL187618B1 (no)
PT (1) PT880520E (no)
SK (1) SK283299B6 (no)
UA (1) UA67724C2 (no)
WO (1) WO1997029107A1 (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITFI970193A1 (it) * 1997-08-01 1999-02-01 Applied Research Systems Uso di derivati benzo(c) chinolizinici come regolatori della crescita delle piante e composizioni ad uso agricolo che contengono tali
EP0926148A1 (en) * 1997-12-23 1999-06-30 Applied Research Systems Ars Holding N.V. Benzo (C)quinolizine derivatives, their preparation and use as 5-alphareductases inhibitors
DE69911430T2 (de) * 1998-08-03 2004-07-22 Applied Research Systems Ars Holding N.V. Verfahren zur herstellung von 1-(1h)-benzoquinolizin-3-on derivaten
ES2600460T3 (es) 2005-05-10 2017-02-09 Intermune, Inc. Derivados de piridona-2-ona como moduladores del sistema de proteína cinasa activada por estrés
JP5463034B2 (ja) * 2005-05-20 2014-04-09 アラントス・フアーマシユーテイカルズ・ホールデイング・インコーポレイテツド ピリミジン若しくはトリアジン縮合二環式メタロプロテアーゼ阻害薬
US20070155738A1 (en) * 2005-05-20 2007-07-05 Alantos Pharmaceuticals, Inc. Heterobicyclic metalloprotease inhibitors
CA2726588C (en) 2008-06-03 2019-04-16 Karl Kossen Compounds and methods for treating inflammatory and fibrotic disorders
AR092742A1 (es) 2012-10-02 2015-04-29 Intermune Inc Piridinonas antifibroticas
WO2015153683A1 (en) 2014-04-02 2015-10-08 Intermune, Inc. Anti-fibrotic pyridinones
CN105001216B (zh) * 2015-07-08 2017-03-01 中国科学院兰州化学物理研究所 一种喹嗪酮的制备方法
CN107089980B (zh) * 2017-05-11 2019-08-30 合肥工业大学 一种手性苯并[a]喹嗪-2-酮类化合物及其不对称催化合成方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1534278A (fr) * 1966-08-15 1968-07-26 Bristol Myers Co Procédé de fabrication de 1, 4-dihydroquinoléine-n-carboxylates d'alcoyle
US3455929A (en) * 1966-08-15 1969-07-15 Bristol Myers Co Esters of 1,4-dihydroquinoline-n-carboxylic acids and thione acids
US3625877A (en) * 1968-01-08 1971-12-07 Eastman Kodak Co High-modulus polycarbonate compositions
SU1027166A1 (ru) * 1981-09-11 1983-07-07 Киевский Ордена Ленина Государственный Университет Им.Т.Г.Шевченко Способ получени 1,2-полиметиленкетоцианоазагетероциклов
IE57014B1 (en) 1983-03-25 1992-03-11 Wyeth John & Brother Ltd Benzoquinolizines

Also Published As

Publication number Publication date
PL187618B1 (pl) 2004-08-31
PT880520E (pt) 2003-07-31
AU1767297A (en) 1997-08-28
CN1210536A (zh) 1999-03-10
NZ331256A (en) 1999-06-29
SK283299B6 (sk) 2003-05-02
US6552034B2 (en) 2003-04-22
MX9806229A (es) 1998-11-30
DK0880520T3 (da) 2003-08-11
DE69720966T2 (de) 2004-05-19
BG64596B1 (bg) 2005-08-31
US20010047098A1 (en) 2001-11-29
KR19990082126A (ko) 1999-11-15
SK104498A3 (en) 1998-12-02
NO320155B1 (no) 2005-11-07
IL125628A (en) 2006-10-31
CN1116296C (zh) 2003-07-30
PL328123A1 (en) 1999-01-18
AU711886C (en) 2002-10-17
CZ228998A3 (cs) 1998-10-14
NO983444D0 (no) 1998-07-24
EP0880520B1 (en) 2003-04-16
IL125628A0 (en) 1999-04-11
IT1286545B1 (it) 1998-07-15
US20010044542A1 (en) 2001-11-22
EP0880520A1 (en) 1998-12-02
EE04058B1 (et) 2003-06-16
EA199800701A1 (ru) 1999-02-25
ATE237614T1 (de) 2003-05-15
KR100480448B1 (ko) 2005-08-31
NO983444L (no) 1998-07-24
HUP9900509A2 (hu) 1999-06-28
JP2000504680A (ja) 2000-04-18
HUP9900509A3 (en) 1999-11-29
EA000975B1 (ru) 2000-08-28
US6555549B2 (en) 2003-04-29
ITFI960019A0 (no) 1996-02-09
AU711886B2 (en) 1999-10-21
ITFI960019A1 (it) 1997-08-09
HK1018783A1 (en) 2000-01-07
CZ298061B6 (cs) 2007-06-06
WO1997029107A1 (en) 1997-08-14
EE9800233A (et) 1998-12-15
BG102661A (en) 1999-04-30
ES2192263T3 (es) 2003-10-01
UA67724C2 (en) 2004-07-15
DE69720966D1 (de) 2003-05-22
US6303622B1 (en) 2001-10-16

Similar Documents

Publication Publication Date Title
NO20020391L (no) 8-Fenyl-6,9-dihydro-[1,2,4]-triazolo [3,4-i]-purin-5-on- derivater
DE69904302T2 (de) Farnesyltransferase-inhibitoren mit piperidinstruktur und verfahren zu ihrer herstellung
DK0889877T3 (da) Meta-substituerede phenylenderivater og deres anvendelse som alfav-beta3-integrin-antagonister eller -inhibitorer
DK0894084T3 (da) Kanelsyrederivater og deres anvendelse som integrinantagonister
DK0891325T3 (da) Para-substituerede phenylpropansyrederivater som integrinantagonister
NO20050666L (no) 2,7-substituerte indoler og deres anvendelse som 5-HT6 modulatorer
NO20045132L (no) Benzo(c)kinolizinderivater, deres fremstilling og anvendelse som 5alfa- reduktaseinhibitorer
NO941977L (no) Indolderivater, fremgangsmåte for fremstilling av disse, og medisinsk anvendelse derav
NO984740L (no) Isatinderivater som acetylcholinesteraseinhibitorer og analgetiske midler
DK1165544T3 (da) Substituerede 1,4-dihydroindeno[1,2-c]pyrazoler som inhibitorer af tyrosinkinase
ATE253359T1 (de) Antithrombotische mittel
NO20022123L (no) Osoksazolderivater for anvendelse som inhibitorer for fosfodiesterase VII
NO991589L (no) Nye 3-,5- og/eller 6-substituerte analoger av swainsonin, fremgangsmÕter for deres fremstilling og deres anvendelse som terapeutiske midler
EP1027051A4 (en) ANTITHROMBOTIC AGENTS
NO992009L (no) Nye trans-3,4-kromanderivater som kan anvendes ved forhindring eller behandling av °strogenrelaterte sykdommer eller syndromer
ATE241624T1 (de) Benzo(f)naphthyridinderivate, ihre herstellung und sie enthaltende pharmazeutische zusammenstzungen
DE69927997D1 (de) Neuartige pyrimidin-derivate und verfahren zu ihrer herstellung
NO20013601L (no) Nye morfolinobenzamidsalter
WO2002018363A3 (en) 3-phenyl-propanoic acid derivatives as protein tyrosine phosphatase inhibitors
NO20035026D0 (no) Dihydroimidazo [5,1-A]-<beta>-karbolinderivater, fremgangsmåte til deres fremstilling og anvendelse derav som legemiddel
WO2000037465A3 (en) Novel derivatives of swainsonine, processes for their preparation, and their use as therapeutic agents
CA2245758A1 (en) Benzo[c]quinolizine derivatives, their preparation and use as 5.alpha.-reductases inhibitors
DE69824410D1 (en) Antithrombosemittel
AU1434201A (en) Antithrombotic agents

Legal Events

Date Code Title Description
CREP Change of representative

Representative=s name: ONSAGERS AS, POSTBOKS 6963 ST OLAVS PLASS, 0130 OS

FC2A Withdrawal, rejection or dismissal of laid open patent application